Synosia Therapeutics Announces Appointment of Vice President of Clinical Research and Development

SAN FRANCISCO, CA, Nov. 5 /CNW/ - Synosia Therapeutics today announced the appointment of Uwe Meya, M.D., as the company's new vice president of clinical research and development, effective immediately.
MORE ON THIS TOPIC